title: Human T-Lymphotropic Virus (HTLV) Type I in vivo Integration in Oral Keratinocytes.
abstract: Although the infection of HTLV-1 to cell components of the mouth have been previously reported, there was not until this report, a detailed study to show the characteristics of such infection. From 14 Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (HAM/TSP) patients and 11 asymptomatic carrier individuals (AC) coming from HTLV-1 endemic areas of southwest Pacific of Colombia, infected oral mucosa cells were primary cultured during five days. These cell cultures were immunophenotyped by dual color fluorescence cell assortment using different lymphocyte CD markers and also were immunohistochemically processed using a polyclonal anti-keratin antibody. Five days old primary cultures were characterized as oral keratinocytes, whose phenotype was CD3- /CD4-/CD8-/CD19-/CD14-/CD45-/A575-keratin+. From DNA extracted of primary cultures LTR, pol, env and tax HTLV-1 proviral DNA regions were differentially amplified by PCR showing proviral integration. Using poly A+ RNA obtained of these primary cultures, we amplify by RT-PCR cDNA of tax and pol in 57.14% (8/14) HAM/TSP patients and 27.28% (3/11) AC. Tax and pol poly A+ RNA were expressed only in those sIgA positive subjects. Our results showed that proviral integration and viral gene expression in oral keratinocytes are associated with a HTLV-1 specific local mucosal immune response only in those HTLV-1 infected individuals with detectable levels of sIgA in their oral fluids. Altogether the results gave strong evidence that oral mucosa infection would be parte of the systemic spreading of HTLV-1 infection.
authors.affiliation: Laboratory of Molecular Biology and Pathogenesis. Department of Physiological Sciences. Faculty of Health . University of Valle, Cali , Colombia .
authors.forename: Martha C
authors.initials: MC
authors.lastname: Domínguez
authors.forename: Norma
authors.initials: N
authors.lastname: Enith González
authors.forename: Adalberto
authors.initials: A
authors.lastname: Sánchez
authors.forename: Felipe
authors.initials: F
authors.lastname: García Vallejo
keywords: Human T-Lymphotropic virus type 1; Oral keratinocytes; Oral mucosa; Proviral integration; sIgA
references.citation: J Gynecol Obstet Biol Reprod (Paris). 2004 Feb;33(1 Pt 1):14-20
references.pmid: 14968050
references.citation: J Virol. 2007 Feb;81(3):1506-10
references.pmid: 17108050
references.citation: Virology. 2006 Sep 15;353(1):99-110
references.pmid: 16781755
references.citation: J Med Virol. 2004 Oct;74(2):323-7
references.pmid: 15332282
references.citation: Antimicrob Agents Chemother. 2008 Aug;52(8):2771-9
references.pmid: 18505856
references.citation: Lancet Infect Dis. 2007 Apr;7(4):266-81
references.pmid: 17376384
references.citation: J Infect Dis. 1991 Jan;163(1):47-52
references.pmid: 1984476
references.citation: Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9
references.pmid: 6261256
references.citation: Med Microbiol Immunol. 2006 Jun;195(2):93-9
references.pmid: 16220308
references.citation: J Infect Dis. 2004 Oct 1;190(7):1275-8
references.pmid: 15346338
references.citation: Cancer Res. 1991 Sep 1;51(17):4639-42
references.pmid: 1873809
references.citation: Rev Stomatol Chir Maxillofac. 2008 Jun;109(3):153-7
references.pmid: 18374956
references.citation: J Mol Biol. 1975 Nov 5;98(3):503-17
references.pmid: 1195397
references.citation: Virus Res. 2003 Feb;91(2):231-9
references.pmid: 12573502
references.citation: J Virol. 2007 Jun;81(11):5714-23
references.pmid: 17344291
references.citation: Cancer Sci. 2007 Jun;98(6):772-8
references.pmid: 17388788
references.citation: Lancet. 1986 May 3;1(8488):1031-2
references.pmid: 2871307
references.citation: Vox Sang. 1984;46(5):245-53
references.pmid: 6328765
references.citation: J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jun 1;12(2):193-201
references.pmid: 8680892
references.citation: Science. 2003 Mar 14;299(5613):1713-6
references.pmid: 12589003
references.citation: J Med Virol. 2002 Jan;66(1):102-6
references.pmid: 11748665
references.citation: Anal Biochem. 1992 Mar;201(2):331-5
references.pmid: 1632522
references.citation: Anal Biochem. 1976 May 7;72:248-54
references.pmid: 942051
references.citation: J Virol. 1991 Oct;65(10):5471-6
references.pmid: 1895396
references.citation: AIDS Res Hum Retroviruses. 1997 Aug 10;13(12):1067-70
references.pmid: 9264294
references.citation: Cell. 2003 Nov 14;115(4):449-59
references.pmid: 14622599
references.citation: Leuk Res. 1985;9(11):1305-14
references.pmid: 3001435
references.citation: Ann Neurol. 1988;23 Suppl:S174-80
references.pmid: 2894810
references.citation: J Clin Microbiol. 1995 Jun;33(6):1510-5
references.pmid: 7650176
references.citation: Ann Neurol. 1987 Feb;21(2):117-22
references.pmid: 2881513
references.citation: Neurol Sci. 2006 Sep;27(4):257-60
references.pmid: 16998729
references.citation: Oncogene. 2005 Sep 5;24(39):6058-68
references.pmid: 16155612
references.citation: Int J Cancer. 1999 Sep 9;82(6):832-6
references.pmid: 10446450
references.citation: Microbiol Mol Biol Rev. 2001 Sep;65(3):371-89, table of contents
references.pmid: 11528001
references.citation: J Clin Microbiol. 1998 Jun;36(6):1811-3
references.pmid: 9620431
references.citation: Arch Virol. 1998;143(5):1029-34
references.pmid: 9645208
references.citation: Viral Immunol. 1995;8(3):141-50
references.pmid: 8833267
references.citation: Clin Lab Haematol. 2005 Aug;27(4):235-41
references.pmid: 16048490